MIRUM PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.3 USD | +5.11% |
|
+2.10% | -14.30% |
| May. 10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
| May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart calendar Mirum Pharmaceuticals, Inc.
e4aaeb7202e2.aw6OCy74nC0DugT1AF0eHZ2_jjlfKFdxJsMykknOKPI.A2C-c3SN5nRLzWjHLRF7f6_R70EyHDFESoZj4iqha5sOZ-85G5v6S3ffSQ~cf85a86eff2aa928350e339bbf2199ff
Upcoming events on Mirum Pharmaceuticals, Inc.
Past events on Mirum Pharmaceuticals, Inc.
| 2024-05-14 01:30 pm | Citizens JMP Life Sciences Conference |
| 2024-05-08 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-08 04:02 pm | Q1 2024 Earnings Release |
| 2024-03-12 | Barclays Global Healthcare Conference |
| 2024-03-12 03:00 pm | Leerink Partners Global Biopharma Conference |
| 2024-02-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-28 04:03 pm | Q4 2023 Earnings Release |
| 2024-01-10 01:30 pm | JPMorgan Healthcare Conference |
| 2023-11-28 03:25 pm | Evercore ISI HealthCONx Conference |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 4547-C |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 4605-C |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 4604-C |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 4602-C |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 5048-C |
| 2023-11-08 02:00 pm | UBS BioPharma Conference - Fireside Chat |
| 2023-11-02 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-02 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-07 03:00 pm | North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No |
| 2023-10-07 03:00 pm | North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No |
| 2023-10-07 03:00 pm | North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 8,33 - | 19,1 78,4 -75.6% | 77,1 74,1 3.93% | 186 185 0.96% | 316 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -173 -169 -2.26% | -128 -138 7.01% | 0,00 -101 - | -65,4 |
|
EBIT Million USD | Released Forecast Spread | -54,7 -53,1 -3% | -104 -91,8 -13.67% | -173 -141 -22.67% | -131 -132 0.81% | -107 -95,3 -11.91% | -76,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,5 -51,7 -1.61% | -103 -90,1 -14.64% | -84,0 -137 38.87% | -142 -145 1.86% | -160 -139 -15.44% | -76,2 |
|
Net income Million USD | Released Forecast Spread | -52,6 -51,7 -1.65% | -103 -90,1 -14.65% | -84,0 -129 34.7% | -136 -137 1.18% | -161 -141 -14.39% | -66,0 |
|
EPS USD | Released Forecast Spread | -4,58 -3,68 -24.46% | -4,09 -3,57 -14.49% | -2,77 -4,51 38.62% | -4,02 -3,92 -2.61% | -3,94 -3,45 -14.18% | -1,33 |
| Announcement Date | 12/03/20 | 09/03/21 | 09/03/22 | 08/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12,9 8,46 52.33% | 17,5 15,4 13.41% | 18,8 20,8 -9.75% | 27,9 25,1 11.27% | 31,6 30,8 2.62% | 37,5 30,4 23.17% | 47,7 38,6 23.66% | 69,6 67,9 2.5% | 69,2 70,2 -1.35% | 75,3 | 82,1 | 88,8 | 90,2 | 98,3 |
|
EBITDA Million USD | Released Forecast Spread | -32,4 -36,0 10.02% | -30,8 -27,0 -14.23% | -31,4 -32,0 1.74% | -25,8 -27,0 4.4% | -10,0 | -20,8 -20,4 -1.78% | -13,1 | -5,36 | -1,11 | |||||
|
EBIT Million USD | Released Forecast Spread | -32,7 -43,6 24.95% | -31,4 -35,8 12.08% | -32,9 -31,8 -3.51% | -34,2 -32,0 -6.8% | -27,1 -30,7 11.56% | -24,3 -27,6 11.99% | -25,1 -27,9 9.85% | -30,1 -11,3 -165.45% | -26,5 -25,5 -3.88% | -22,7 | -16,8 | -12,9 | -7,83 | -0,64 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -36,6 -45,8 20.14% | -33,5 -37,7 11.27% | -35,7 -34,1 -4.66% | -36,3 -38,6 5.91% | -29,9 -33,9 11.65% | -73,7 -29,7 -147.92% | -23,3 -28,4 17.7% | -32,9 -11,2 -194.88% | -24,7 -26,3 6.41% | -23,6 | -16,6 | -14,0 | -8,79 | -1,61 |
|
Net income Million USD | Released Forecast Spread | -36,6 -43,6 16.11% | -26,9 -36,8 26.82% | -35,7 -34,9 -2.25% | -36,4 -36,5 0.07% | -30,1 -33,7 10.59% | -74,0 -29,5 -150.74% | -23,6 -28,2 16.43% | -33,1 -12,6 -164.01% | -25,3 -21,6 -16.88% | -20,4 | -14,0 | -7,85 | -8,72 | -1,58 |
|
EPS USD | Released Forecast Spread | -1,17 -1,40 16.5% | -0,84 -1,15 27.2% | -1,02 -1,07 4.65% | -0,99 -1,02 2.55% | -0,80 -0,94 14.81% | -1,94 -0,80 -143.89% | -0,57 -0,63 9.27% | -0,63 -0,25 -151.9% | -0,54 -0,40 -34.58% | -0,44 | -0,31 | -0,18 | -0,18 | -0,04 |
| Announcement Date | 05/05/22 | 04/08/22 | 09/11/22 | 08/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 28/02/24 | 08/05/24 | - | - | - | - | - |
| Today 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
Past sector events for Mirum Pharmaceuticals, Inc.
| Today | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MIRM Stock
- Calendar Mirum Pharmaceuticals, Inc.